List of Tables
    Table 1. Molecular Diagnostics Cancer Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Molecular Diagnostics Cancer Market Trends
    Table 3. Molecular Diagnostics Cancer Market Drivers
    Table 4. Molecular Diagnostics Cancer Market Challenges
    Table 5. Molecular Diagnostics Cancer Market Restraints
    Table 6. Global Molecular Diagnostics Cancer Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Molecular Diagnostics Cancer Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Molecular Diagnostics Cancer Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Molecular Diagnostics Cancer Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Molecular Diagnostics Cancer Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Molecular Diagnostics Cancer Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Molecular Diagnostics Cancer Revenue Share by Player, 2017-2022
    Table 13. Global Molecular Diagnostics Cancer Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Molecular Diagnostics Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Cancer as of 2021)
    Table 15. Top Players of Molecular Diagnostics Cancer in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Molecular Diagnostics Cancer Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Molecular Diagnostics Cancer Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Molecular Diagnostics Cancer Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Molecular Diagnostics Cancer Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Molecular Diagnostics Cancer Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Molecular Diagnostics Cancer Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Molecular Diagnostics Cancer Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Molecular Diagnostics Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Molecular Diagnostics Cancer Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Molecular Diagnostics Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Molecular Diagnostics Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Molecular Diagnostics Cancer Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Roche Company Details
    Table 31. Roche Business Overview
    Table 32. Roche Molecular Diagnostics Cancer Product
    Table 33. Roche Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 34. Roche Recent Development
    Table 35. Danaher Company Details
    Table 36. Danaher Business Overview
    Table 37. Danaher Molecular Diagnostics Cancer Product
    Table 38. Danaher Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 39. Danaher Recent Development
    Table 40. Siemens Company Details
    Table 41. Siemens Business Overview
    Table 42. Siemens Molecular Diagnostics Cancer Product
    Table 43. Siemens Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 44. Siemens Recent Development
    Table 45. Abbott Laboratories Company Details
    Table 46. Abbott Laboratories Business Overview
    Table 47. Abbott Laboratories Molecular Diagnostics Cancer Product
    Table 48. Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 49. Abbott Laboratories Recent Development
    Table 50. ICON Plc Company Details
    Table 51. ICON Plc Business Overview
    Table 52. ICON Plc Molecular Diagnostics Cancer Product
    Table 53. ICON Plc Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 54. ICON Plc Recent Development
    Table 55. AstraZeneca Company Details
    Table 56. AstraZeneca Business Overview
    Table 57. AstraZeneca Molecular Diagnostics Cancer Product
    Table 58. AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 59. AstraZeneca Recent Development
    Table 60. MDxHealth Company Details
    Table 61. MDxHealth Business Overview
    Table 62. MDxHealth Molecular Diagnostics Cancer Product
    Table 63. MDxHealth Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 64. MDxHealth Recent Development
    Table 65. Invitae Company Details
    Table 66. Invitae Business Overview
    Table 67. Invitae Molecular Diagnostics Cancer Product
    Table 68. Invitae Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 69. Invitae Recent Development
    Table 70. PlexBio Company Details
    Table 71. PlexBio Business Overview
    Table 72. PlexBio Molecular Diagnostics Cancer Product
    Table 73. PlexBio Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 74. PlexBio Recent Development
    Table 75. Thermo Fisher Scientific Company Details
    Table 76. Thermo Fisher Scientific Business Overview
    Table 77. Thermo Fisher Scientific Molecular Diagnostics Cancer Product
    Table 78. Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 79. Thermo Fisher Scientific Recent Development
    Table 80. Guardant Health Company Details
    Table 81. Guardant Health Business Overview
    Table 82. Guardant Health Molecular Diagnostics Cancer Product
    Table 83. Guardant Health Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 84. Guardant Health Recent Development
    Table 85. Biocartis Company Details
    Table 86. Biocartis Business Overview
    Table 87. Biocartis Molecular Diagnostics Cancer Product
    Table 88. Biocartis Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 89. Biocartis Recent Development
    Table 90. Bio-Techne Company Details
    Table 91. Bio-Techne Business Overview
    Table 92. Bio-Techne Molecular Diagnostics Cancer Product
    Table 93. Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 94. Bio-Techne Recent Development
    Table 95. Merck Company Details
    Table 96. Merck Business Overview
    Table 97. Merck Molecular Diagnostics Cancer Product
    Table 98. Merck Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 99. Merck Recent Development
    Table 100. Foundation Medicine Company Details
    Table 101. Foundation Medicine Business Overview
    Table 102. Foundation Medicine Molecular Diagnostics Cancer Product
    Table 103. Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 104. Foundation Medicine Recent Development
    Table 105. 10X Genomics Company Details
    Table 106. 10X Genomics Business Overview
    Table 107. 10X Genomics Molecular Diagnostics Cancer Product
    Table 108. 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 109. 10X Genomics Recent Development
    Table 110. Biodesix Company Details
    Table 111. Biodesix Business Overview
    Table 112. Biodesix Molecular Diagnostics Cancer Product
    Table 113. Biodesix Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 114. Biodesix Recent Development
    Table 115. CytoTrack Company Details
    Table 116. CytoTrack Business Overview
    Table 117. CytoTrack Molecular Diagnostics Cancer Product
    Table 118. CytoTrack Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 119. CytoTrack Recent Development
    Table 120. GenomOncology Company Details
    Table 121. GenomOncology Business Overview
    Table 122. GenomOncology Molecular Diagnostics Cancer Product
    Table 123. GenomOncology Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 124. GenomOncology Recent Development
    Table 125. Luminex Company Details
    Table 126. Luminex Business Overview
    Table 127. Luminex Molecular Diagnostics Cancer Product
    Table 128. Luminex Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million)
    Table 129. Luminex Recent Development
    Table 130. Research Programs/Design for This Report
    Table 131. Key Data Information from Secondary Sources
    Table 132. Key Data Information from Primary Sources
List of Figures
    Figure 1. Molecular Diagnostics Cancer Product Picture
    Figure 2. Global Molecular Diagnostics Cancer Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Molecular Diagnostics Cancer Market Size 2017-2028 (US$ Million)
    Figure 4. United States Molecular Diagnostics Cancer Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Molecular Diagnostics Cancer Market Size 2017-2028 (US$ Million)
    Figure 6. United States Molecular Diagnostics Cancer Market Share in Global 2017-2028
    Figure 7. Molecular Diagnostics Cancer Report Years Considered
    Figure 8. Product Picture of Pharmacogenomic Diagnosis
    Figure 9. Product Picture of Liquid Biopsy
    Figure 10. Product Picture of Other
    Figure 11. Global Molecular Diagnostics Cancer Market Share by Type in 2022 & 2028
    Figure 12. Global Molecular Diagnostics Cancer Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Molecular Diagnostics Cancer Market Share by Type (2017-2028)
    Figure 14. United States Molecular Diagnostics Cancer Market Share by Type in 2022 & 2028
    Figure 15. United States Molecular Diagnostics Cancer Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Molecular Diagnostics Cancer Market Share by Type (2017-2028)
    Figure 17. Product Picture of Respiratory Cancer
    Figure 18. Product Picture of Cancer of Digestive System
    Figure 19. Product Picture of Cancer of Urinary System
    Figure 20. Product Picture of Cancer of Circulatory System
    Figure 21. Product Picture of Motor System Cancer
    Figure 22. Product Picture of Reproductive System Cancer
    Figure 23. Product Picture of Other
    Figure 24. Global Molecular Diagnostics Cancer Market Share by Application in 2022 & 2028
    Figure 25. Global Molecular Diagnostics Cancer Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. Global Molecular Diagnostics Cancer Market Share by Application (2017-2028)
    Figure 27. United States Molecular Diagnostics Cancer Market Share by Application in 2022 & 2028
    Figure 28. United States Molecular Diagnostics Cancer Market Size by Application (2017-2028) & (US$ Million)
    Figure 29. United States Molecular Diagnostics Cancer Market Share by Application (2017-2028)
    Figure 30. North America Molecular Diagnostics Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. U.S. Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Canada Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Europe Molecular Diagnostics Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 34. Germany Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. France Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. U.K. Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Italy Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Russia Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Asia-Pacific Molecular Diagnostics Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 40. China Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Japan Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. South Korea Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. India Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Australia Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Taiwan Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Indonesia Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Thailand Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Malaysia Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Philippines Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Latin America Molecular Diagnostics Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Mexico Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Brazil Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Argentina Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Middle East & Africa Molecular Diagnostics Cancer Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 55. Turkey Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. U.A.E Molecular Diagnostics Cancer Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Roche Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 59. Danaher Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 60. Siemens Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 61. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 62. ICON Plc Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 63. AstraZeneca Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 64. MDxHealth Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 65. Invitae Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 66. PlexBio Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 68. Guardant Health Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 69. Biocartis Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 70. Bio-Techne Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 71. Merck Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 72. Foundation Medicine Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 73. 10X Genomics Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 74. Biodesix Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 75. CytoTrack Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 76. GenomOncology Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 77. Luminex Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022)
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed